Transvascular develops products for the treatment of coronary and peripheral vascular disease and congestive heart failure.
Transvascular develops products for the treatment of coronary and peripheral vascular disease and congestive heart failure.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Jul 1, 2002 | Series D | $10.80M | 2 | — | — | Detail |